A Columbia Care cannabis dispensary in the Chicago area.
Business Wire
When recreational sales of marijuana begin next year in New York, Columbia Care will be ready. Last month, the cannabis seller acquired a million square feet of growing capacity on the North Fork of the state’s Long Island.
“We are now the largest grower in New York,” Chief Executive Nick Vita told Barron’s on Monday afternoon, after Columbia Care (ticker: CCHWF) released its financial results for the March quarter. The news, disclosed before the market opened, was met by a 2% decline in Columbia’s stock price, to $6.03, while the Nasdaq Composite Index lost 0.4%.
American cannabis companies are among the country’s fastest-growing industries, but the stocks peaked in February.
March quarter sales at the New York-based chain weren’t as large as those at industry leaders like Curaleaf Holdings (CURLF) or Green Thumb Industries (GTBIF), but Columbia Care’s sales are growing fast. March revenue rose 220% over the year-earlier quarter, to $93 million, leaving a loss of $15 million, or 5 cents a share. Earnings before interest, taxes, depreciation, and amortization came to $10 million, excluding noncash and one-time charges.
At about 10% of revenue, those Ebitda margins trailed behind what investors saw at Trulieve Cannabis (TCNNF)—where concentrated sales in Florida allowed March quarter Ebitda margins of 47%— or Green Thumb, with March Ebitda margins of 37%.
Vita says that Columbia’s margins reflect its multistate investments. At 18 states, Columbia’s reach ranks second only to Curaleaf ‘s 23. Curaleaf had a March quarter Ebitda margin of 24%.
“We have more markets that are going through significant capital expenditure right now,” Vita told Barron’s. Columbia is first targeting growth, he said, and then margin expansion. Sales are expected to boom in many states where the company is licensed.
Next year, for example, New Jersey and New York will allow recreational sales to adults. Even before then, New York will permit the sale of dried cannabis flower to medical customers—a change that stimulated sales, when it happened in medical marijuana markets like Florida and Pennsylvania. As the largest cultivation site on the East Coast, Columbia’s Long Island location will have room to host small operators licensed under New York’s social equity provisions.
Vita says that Columbia’s investments will start to show up in its profit margins. “We’re about a quarter away from seeing all those benefits materialize,” he said.
Write to Bill Alpert at [email protected]
